The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
which is targeting specific cellular Pathways that some people have deemed potentially interesting for longevity and the pathway that we're going to spend some time on is the so-call NAD pathway NR nmn NAD being the major players and we'll talk about some of the biochemical and enzymatic steps in between
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.